As Amgen announces additional investments in Ohio, questions arise about the future of a key tax policy that could impact the ...

Pharmaceutical stocks boomeranged Monday after Trump signed an executive order tying drug prices in the U.S. to international ...

It’s been 19 months since Amgen completed its $27.8 billion acquisition of Horizon Therapeutics, and the California company ...

Amgen on Thursday said its first-quarter profit rose 24%, driven by product sales, and said that while it is premature to ...

Like fellow Big Pharmas Eli Lilly and Johnson & Johnson, Amgen is urging the Trump administration to consider tax policy ...

By Sriparna Roy and Joel Jose (Reuters) -Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts ...

Some research has shown that dividend-paying stocks significantly outperformed their non-dividend-paying peers over the past ...

The FDA has freed Amgen’s mysterious early-stage obesity asset from a clinical hold, with the phase 1 study now enrolling participants. | The FDA has freed Amgen’s mysterious early-stage obesity asset ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options ...

Under this new initiative, the US government will give pharmaceutical companies specific price targets to meet within the ...

Amgen (AMGN) stock in focus as its antibody drug Tepezza becomes U.K.'s first medicine for adults with moderate to severe ...

but tax policy," Amgen CFO Peter Griffith said on a conference call. Johnson & Johnson CEO Joaquin Duato last month said tariffs on pharmaceuticals can create supply chain disruptions and ...